CME EPS - Earnings Per Share
Cme Group Inc earnings per share history and growth analysis
Current EPS (Basic)
N/A
Trailing Twelve Months
Stock Price
$0.00
EPS Growth
YoY Growth
0.0%
1-Year Growth
+30.8%
Average EPS
$8.91
EPS History
| Period | Basic EPS | Diluted EPS | Revenue | Net Income |
|---|---|---|---|---|
| FY(0.0%) | $9.69 | $9.67 | $6.13B | $3.53B |
| Q4 2024(+9.2%) | $9.69 | $9.67 | $6.13B | $3.53B |
| FY(0.0%) | $8.87 | $8.86 | $5.58B | $3.23B |
| Q4 2023(+19.7%) | $8.87 | $8.86 | $5.58B | $3.23B |
| FY | $7.41 | $7.40 | $5.02B | $2.69B |
Understanding CME EPS
What EPS Tells You
- Measures profitability on a per-share basis
- Higher EPS generally means better performance
- Used to calculate P/E ratio and PEG ratio
- Growing EPS often drives stock prices higher
How to Use EPS
- Compare EPS growth to industry peers
- Look for consistent EPS growth over time
- Check if EPS beats analyst estimates
- Compare basic vs diluted for dilution impact
Get Full CME Financial Analysis
Deep dive into financials, ratios, and AI-powered insights
Frequently Asked Questions
What is CME EPS (earnings per share)?
CME (Cme Group Inc) EPS data is shown in the historical earnings table above. EPS represents how much profit the company generates per share.
What is the difference between basic and diluted EPS for CME?
Basic EPS is calculated using only outstanding common shares, while diluted EPS accounts for all potential shares that could be created through stock options, warrants, and convertible securities. Diluted EPS is typically lower and provides a more conservative measure of earnings per share.
How has CME EPS grown over time?
CME's most recent year-over-year EPS growth is 0.0%. Over the past year, EPS has grown +30.8%. EPS has declined, which may signal challenges in profitability.
What do analysts expect for CME EPS?
Analyst EPS estimates for CME can be found on the full stock analysis page. These estimates represent the consensus view of Wall Street analysts covering the stock.
Why is EPS important for CME investors?
EPS is one of the most important metrics for evaluating CME's profitability. Growing EPS typically leads to stock price appreciation, while declining EPS can indicate business challenges. EPS is also used to calculate other key metrics like the P/E ratio.
How is CME EPS calculated?
EPS is calculated by dividing net income by the weighted average shares outstanding. For CME, this calculation is performed each quarter when the company reports earnings. Basic EPS uses actual shares outstanding, while diluted EPS includes potential dilution from stock options and convertible securities.